The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Freezing of Gait Program, 2025AID-FOG: Artificial Intelligence-driven Freezing of Gait Detection in the Home
Study Rationale: Freezing of gait (FOG) is a symptom that causes many people with Parkinson’s disease (PD) to suddenly lose their ability to take a step while walking, creating a high risk for falling...
-
Neuronal Synuclein Disease Endotypes 2024, 2025Assessing the Aggregation of Alpha-synuclein Across Aging, Alzheimer’s Disease and Dementia with Lewy Bodies
Study Rationale: Forms of alpha-synuclein, the protein that aggregates in Parkinson’s disease (PD), can be detected in cerebrospinal fluid (CSF) by seed amplification assays (SAA). These highly...
-
Neuronal Synuclein Disease Endotypes 2024, 2025Testing Biofluid Samples from the Arizona Study of Aging and Neurodegenerative Disorders for Alpha-synuclein and Biomarkers of Alzheimer’s Disease
Study Rationale: The Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) has amassed a comprehensive collection of samples and longitudinal clinicopathological data. In this project, we...
-
Research Grant, 2025Evaluation of Novel PET Probes for Alpha-synuclein Imaging
Study Rationale: Aggregation of the protein alpha-synuclein into fibrils in Lewy bodies and Lewy neurites is the key pathological feature of Parkinson's disease (PD) and related synucleinopathies...
-
Research Grant, 2025Assessment of Artificial Intelligence (AI) and Blood-Brain Barrier Technology
Study Rationale: Companies are currently using artificial intelligence (AI) to design and develop new drugs and developing new ways to get drugs across the protective blood-brain barrier (BBB) and...
-
, 2022Uncovering Proteomic Alterations in Parkinson’s Disease Using Patient-specific iPSC-derived Brain Cells
Study Rationale: Transgenic small models have been used as gold standard to study human brain diseases, but it is unclear how conclusive and faithfully these models reflect pathophysiological...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.